Chondroitin sulfate glycosaminoglycans are two-sugar repeating polymers that display diverse sulfation patterns in vivo.
For the 1st time, chondroitin sulfate has been more successful than celecoxib in reducing the long-term progression of knee osteoarthritis (OA), according to new research findings. Chondroitin sulfate, more commonly called chondroitin, has long been the subject of debate when it comes to its usefulness in treating OA. Canadian researchers recently explored how this treatment would affect how OA progresses as well as how it compared to celecoxib (Celebrex®).
“We felt the present study was necessary in order to establish – using the most recent imaging technology available, quantitative magnetic resonance imaging (qMRI) – whether chondroitin sulfate can truly and effectiv...
Read More
Recent Comments